15,000+ Scientists & Academics
3,000+ Scientific disciplines
7,000+ Projects posted
Trusted by 2,500+ businesses
Why Kolabtree
  • Getting started is quick and easy. No upfront fees
  • It’s free to request a service and invite bids from experts
  • Discuss the project scope and fee and hire the expert who best meets your requirements
  • Collaborate with the expert directly to get your work done the right way
  • Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Request Service
★★★★★
☆☆☆☆☆
USD 180 /hr
Hire Dr. Rob Lambkin-Williams
United Kingdom
USD 180 /hr

Expert Respiratory Virologist including influenza , RSV, rhinovirus and coronavirus (including COVID-19)

Summary
Subject Matter Expertise
Services
Data Science Data visualization, Analysis from dataset, Quantitative analysis
Editing Content editing, Development editing, Fact checking, Proofreading
Statistical review Conduct simple analysis, Other
Secondary Research Literature search, Find latest research, Prepare evidence-based answers, Deep dive into a topic, Research competitors, Prepare a research report, Compile list of papers, Summarize findings
Work Experience
  • CEO and CSO

    Virology Consult Ltd

    July 2019 - Present

  • Consultant

    VirologyConsult.com

    July 2019 - Present

  • Chief Scientific Officer/ Executive Scientific Adviser

    hVIVO (United Kingdom)

    2016 - 2019

  • Chief Scientific Officer

    Retroscreen Virology (United Kingdom)

    2014 - July 2016

  • Founding Scientist through to Chief Executive Officer

    Queen Mary, Uni of London and Retroscreen Virology (United Kingdom)

    May 1995 - 2014

Education
  • PhD

    The University of Warwick

    January 1992 - January 1995

Publications
    CONFERENCE PAPER
  • Bagga, B and Vaishnav, A and Wilkinson, T and Meyers, R and Harrison, L and Roddam, P and Lambkin-Williams, R and DeVincenzo, JP(2012). EFFECT OF MUCOSAL IGA ANTIBODY ON DETECTION OF" CULTURABLE" RSV VIRUS IN EXPERIMENTAL RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS OF ADULTS. JOURNAL OF INVESTIGATIVE MEDICINE. 60. (1). p. 445--445.
  • Karasu, A and Moss, AJ and Gilbert, A and Mann, A and Lambkin-Williams, R and Gelder, CM and Oxford, JS and Gaughran, FB and Powell, F and Oxberry, P and others(2008). HLA class II gene and allele associations with the immune response to influenza vaccination in the elderly. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 35. (6). p. 491--491.
  • Devincenzo, J and Fathi, H and Mcclure, M and Westland, C and Chanda, S and Lambkin-Williams, R and Smith, P and Harrison, L and Symons, J and Scaglioni-Weinlich, CTreatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study. Open Forum Infect Dis. 1. p. S66-S69.
  • Gaughran, Fiona P and Walwyn, Rebecca and Whelan, Paul and Chatterton, Kate and Lambkin, Rob and Oxford, John S and Macdonald, AlastairEffect of influenza vaccine in elderly care home residents-A randomised trial. BIOLOGICAL PSYCHIATRY. 61. p. 142S-142S. ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
  • Sefia, E and Mann, A and Lambkin, R and Balasingham, S and Oxford, J and Simpson, M and Shephard, A and Goulder, MFlurbiprofen lozenges rapidly reduce levels of prostaglandin E in human respiratory cells in vitro. Abstract presented at the Annual Scientific Meeting of the British Pain Society, Glasgow, UK. p. 24-27.
  • Roberts, NA and Carr, JC and Lambkin, ROral administration of the neuraminidase inhibitor prodrug GS4104 blocks influenza virus replication in ferrets. European Respiratory Society Annual Congress. p. 19-23.
  • Carr, J and Ives, J and Roberts, N and Tai, CY and Wang, M and Meng, M and Mendel, D and Kelly, L and Lambkin, R and Oxford, JAn oseltamivir-treatment selected influenzaA/Wuhan/359/95 virus with an E119V mutation in the neuraminidase gene has reduced infectivity in vivo. Second International Symposium for Influenza and Other Respiratory Viruses. The Macrae Group, New York, NY.
  • FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus @inproceedings{RN38089, author= {Fries, Louis and Lambkin, Rob and Gelder, Colin and White, Gregory and Burt, David and Lowell, George and Oxford, John}, title= {FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus}, booktitle= {International Congress Series}, publisher= {Elsevier}, volume= {1263}, pages= {661-665}, ISBN= {0531-5131}, type= {Conference Proceedings}}. International Congress Series.
  • Carr, J and Ives, J and Roberts, N and Kelly, L and Lambkin, R and Oxford, J and Tai, CY and Mendel, D and Hayden, FVirological assessment in vitro and in vivo of an influenza H1N1 virus with a H274Y mutation in the neuraminidase gene. Antiviral research. 46. p. A59-A59. ELSEVIER SCIENCE BV PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
  • McClain, Micah T and Nicholson, Bradly P and Park, Lawrence P and Liu, Tzu-Yu and Hero, Alfred O and Tsalik, Ephraim L and Zaas, Aimee K and Veldman, Timothy and Hudson, Lori L and Lambkin-Williams, RobertA genomic signature of influenza infection shows potential for presymptomatic detection, guiding early therapy, and monitoring clinical responses. Open forum infectious diseases. 3. Oxford University Press
  • LAMBKIN, R and MCLAIN, L and DIMMOCK, NJRAPID ANTIGENIC DRIFT DRIVEN BY IMMUNE SERUM FROM MICE IMMUNIZED WITH INACTIVATED TYPE-A INFLUENZA. JOURNAL OF CELLULAR BIOCHEMISTRY. p. 58-58. WILEY-LISS DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
  • Neutralizing activity of Sambucol® against avian NIBRG‐14 (H5N1) influenza virus @inproceedings{RN38101, author= {Balasingam, S and Lambkin, R and Safirman, D and Mumcuoglu, M and Oxford, J}, title= {Neutralizing activity of Sambucol® against avian NIBRG‐14 (H5N1) influenza virus}, booktitle= {IV International Conference on Influenza, Preventing the Pandemic, Bird Flu Vaccines London}, type= {Conference Proceedings}}. IV International Conference on Influenza, Preventing the Pandemic, Bird Flu Vaccines London.
  • Bagga, B and Vaishnav, A and Wilkinson, T and Meyers, R and Harrison, L and Roddam, P and Lambkin-Williams, R and DeVincenzo, JPEFFECT OF MUCOSAL IGA ANTIBODY ON DETECTION OF" CULTURABLE" RSV VIRUS IN EXPERIMENTAL RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS OF ADULTS. JOURNAL OF INVESTIGATIVE MEDICINE. 60. p. 445-445. LIPPINCOTT WILLIAMS & WILKINS 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
    DISSERTATION THESIS
  • Even-Or, Orli(2011). A Novel Vaccine Against Influenza Based on the Polycationic Sphingolipid Ceramide Carbamoyl-spermine (CCS) as a Carrier/adjuvant for Intramuscular and Intranasal Vaccination.
  • Lambkin, Robert(1994). The selection of influenza A virus escape mutants by antiserum.
    BOOK CHAPTER
  • Oxford, John and Gilbert, Anthony and Lambkin-Williams, Robert(2011). Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A/swine (H1N1) vaccine in the current pandemic. Influenza Vaccines for the Future. p. 115--147. Springer
  • Oxford, John and Lambkin-Williams, Robert and Gilbert, Anthony(2008). Influenza vaccines have a short but illustrious history. Influenza Vaccines for the Future. p. 31-64. Birkhäuser Basel